Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Duster340on Sep 15, 2021 11:00am

207 Views

Post# 33861572

Hope you guys

got in, the entry point was as low as $2.58 this morning, i picked up some more averaged down to $2.60 and sold @ $2.66 for a nice profit. changed my mind on holding longer cause the market just looks tired. i think we could be in for a market correction soon. my advice in this market is to do quick flips nothing wrong with taking profit big or small.i plan on buying back into Hexo and the pot stocks later in the fall for the long term, this is a beaten up sector and will be on the move later in the year and in 2022 with changes to the tax laws and then lagalization in the near future.
glta

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec